Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(32 sites)

China

Shapingba District People's Hospital of Chongqing, Chongqing, Chongqing Municipality

Zhengzhou Seventh People's Hospital, Zhengzhou, Henan

Binzhou Medical University Hospital, Binzhou, Shandong

Binzhou People's Hospital, Binzhou, Shandong

Dezhou Municiple Hospital, Dezhou, Shandong